Table 1:
Yearly PSA screening rates of transgender women and men in Marketscan research databases with 95% confidence intervals
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Any Year | |
|---|---|---|---|---|---|---|---|---|---|
| Transgender women | Number of individuals | 428 | 723 | 697 | 888 | 1,164 | 1,299 | 1,101 | 2,957 |
| Number with PSA screening | 103 | 147 | 148 | 184 | 313 | 331 | 274 | 965 | |
| PSA screening rate (95% CI) | 24.07% (20.15, 28.46) | 20.33% (17.49, 23.49) | 21.23% (18.23, 24.50) | 20.72% (18.13, 23.57) | 26.89% (24.38, 29.55) | 25.48% (23.15, 27.96) | 24.89% (22.38, 27.57) | 32.63% (30.95, 34.36) | |
| Cisgender Men | Number of individuals | 7,933,148 | 8,040,389 | 5,045,691 | 4,865,809 | 4,357,417 | 4,276,782 | 3,311,381 | 14,278,025 |
| Number with PSA screening | 2,297,488 | 2,253,265 | 1,460,275 | 1,387,619 | 1,269,893 | 1,278,918 | 1,027,316 | 5,966,527 | |
| PSA screening rate (95% CI) | 28.96% (28.93, 28.99) | 28.02% (27.99, 28.06) | 28.94% (28.90, 28.98) | 28.52% (28.48, 28.56) | 29.14% (29.10, 29.19) | 29.9% (29.86, 29.95) | 31.02% (30.97, 31.07) | 41.79% (41.76, 41.81) |
Legend:
The proportion of transgender women and cisgender men receiving a PSA screening was calculated on both a year-by-year basis and for the overall proportion who received at least 1 PSA screening during the year(s) in which they were included (which could range from 1 to 7 years if inclusion criteria were met consistently).